Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Qiuxia Yu, Gaoxiang Wang, Jue Wang, Wei Zhang, Li Meng & Yang Cao. (2022) Primary Testicular and Cutaneous Philadelphia Chromosome Positive B-Cell Lymphoblastic Lymphoma: A Rare Case and Review. Cancer Management and Research 14, pages 1507-1514.
Read now
Read now
Elena Forzisi & Federico Sesti. (2022) Non-conducting functions of ion channels: The case of integrin-ion channel complexes. Channels 16:1, pages 185-197.
Read now
Read now
Marie Balsat, Victoria Cacheux, Martin Carre, Emmanuelle Tavernier-Tardy & Xavier Thomas. (2020) Treatment and outcome of Philadelphia chromosome-positive acute lymphoblastic leukemia in adults after relapse. Expert Review of Anticancer Therapy 20:10, pages 879-891.
Read now
Read now
Françoise Huguet. (2015) Dasatinib for acute lymphoblastic leukemia. Expert Opinion on Orphan Drugs 3:11, pages 1339-1356.
Read now
Read now
Charles Chuah & Junia V Melo. (2009) Targeted treatment of imatinib-resistant chronic myeloid leukemia: Focus on dasatinib. OncoTargets and Therapy 2, pages 83-94.
Read now
Read now
Thomas R Webb, Jake Slavish, Rani E George, A Thomas Look, Liquan Xue, Qin Jiang, Xiaoli Cui, Walter B Rentrop & Stephan W Morris. (2009) Anaplastic lymphoma kinase: role in cancer pathogenesis and small-molecule inhibitor development for therapy. Expert Review of Anticancer Therapy 9:3, pages 331-356.
Read now
Read now
Peter Valent. (2007) Imatinib-resistant chronic myeloid leukemia (CML): Current concepts on pathogenesis and new emerging pharmacologic approaches. Biologics: Targets and Therapy 1:4, pages 433-448.
Read now
Read now
Articles from other publishers (13)
Xiaoyuan Gong, Le Li, Hui Wei, Bingcheng Liu, Chunlin Zhou, Guangji Zhang, Kaiqi Liu, Dong Lin, Benfa Gong, Shuning Wei, Yan Li, Yingchang Mi, Ying Wang & Jianxiang Wang. (2021) A Higher Dose of Dasatinib May Increase the Possibility of Crossing the Blood–brain Barrier in the Treatment of Patients With Philadelphia Chromosome–positive Acute Lymphoblastic Leukemia. Clinical Therapeutics 43:7, pages 1265-1271.e1.
Crossref
Crossref
Yu Wei, Mi Ryung Shin & Federico Sesti. (2018) Oxidation of KCNB1 channels in the human brain and in mouse model of Alzheimer’s disease. Cell Death & Disease 9:8.
Crossref
Crossref
SHIUE-WEI LAI, TZU-CHUAN HUANG, JIA-HONG CHEN, YI-YING WU & PING-YING CHANG. (2015) Dasatinib as the salvage therapy for chronic myeloid leukemia with blast crisis and central nervous system involvement: A case report. Oncology Letters 9:4, pages 1957-1961.
Crossref
Crossref
Toshinori Kondo, Taizo Tasaka, Kana Matsumoto, Rui Matsumoto, Lisa Koresawa, Fuminori Sano, Hirotoshi Tokunaga, Yoshiko Matsuhashi, Hidekazu Nakanishi, Kunihiko Morita, Hideho Wada & Takashi Sugihara. (2014) Philadelphia chromosome-positive acute lymphoblastic leukemia with extramedullary and meningeal relapse after allogeneic hematopoietic stem cell transplantation that was successfully treated with dasatinib. SpringerPlus 3:1.
Crossref
Crossref
Diana S. Osorio, Jonathan L. Finlay, Girish Dhall, Stewart Goldman, David Eisenstat & Robert J. Brown. (2013) Feasibility of dasatinib in children and adolescents with new or recurrent central nervous system germinoma. Pediatric Blood & Cancer 60:9, pages E100-E102.
Crossref
Crossref
Mitsutaka Nishimoto, Hirohisa Nakamae, Ki-Ryang Koh, Saori Kosaka, Kana Matsumoto, Kunihiko Morita, Hideo Koh, Takahiko Nakane, Masahiko Ohsawa & Masayuki Hino. (2013) Dasatinib Maintenance Therapy after Allogeneic Hematopoietic Stem Cell Transplantation for an Isolated Central Nervous System Blast Crisis in Chronic Myelogenous Leukemia. Acta Haematologica 130:2, pages 111-114.
Crossref
Crossref
Kapil Bhalla, Celalettin Ustun & Warren Fiskus. 2012. Hematologic Cancers: From Molecular Pathobiology to Targeted Therapeutics. Hematologic Cancers: From Molecular Pathobiology to Targeted Therapeutics
277
314
.
Sotirios G. Papageorgiou, Vasiliki Pappa, Christina Economopoulou, Panagiotis Tsirigotis, Frida Konsioti, Eleni-Dikaia Ionnidou, Spyros Chondropoulos, Diamantina Vasilatou, Efstathios Papageorgiou, Theofanis Economopoulos & John Dervenoulas. (2010) Dasatinib induces long-term remission in imatinib-resistant Philadelphia chromosome-positive acute megakaryoblastic leukemia but fails to prevent development of central nervous system progression. Leukemia Research 34:9, pages e254-e256.
Crossref
Crossref
Philippe Aftimos & Fady Nasr. (2009) Isolated CNS lymphoid blast crisis in a patient with imatinib-resistant chronic myelogenous leukemia: Case report and review of the literature. Leukemia Research 33:11, pages e178-e180.
Crossref
Crossref
Franz Gruber, Satu Mustjoki & Kimmo Porkka. (2009) Impact of tyrosine kinase inhibitors on patient outcomes in Philadelphia chromosome-positive acute lymphoblastic leukaemia. British Journal of Haematology 145:5, pages 581-597.
Crossref
Crossref
Ferdinando Frigeri, Manuela Arcamone, Luigia Luciano, Raffaele Di Francia, Fabrizio Pane & Antonio Pinto. (2009) Systemic dasatinib fails to prevent development of central nervous system progression in a patient with BCR-ABL unmutated Philadelphia chromosome–positive leukemia. Blood 113:20, pages 5028-5029.
Crossref
Crossref
Kimmo Porkka, Perttu Koskenvesa, Tuija LundánJohanna RimpiläinenSatu Mustjoki, Richard SmyklaRobert WildRoger LuoMontserrat ArnanBenoit BrethonLydia EccersleyHenrik Hjorth-HansenMartin HöglundHana KlamovaHåvar KnutsenSuhag ParikhEmmanuel RaffouxFranz GruberFinella Brito-BabapulleHervé DombretRafael F. DuarteErkki Elonen, Ron PaquetteC. Michel Zwaan & Francis Y. F. Lee. (2008) Dasatinib crosses the blood-brain barrier and is an efficient therapy for central nervous system Philadelphia chromosome–positive leukemia. Blood 112:4, pages 1005-1012.
Crossref
Crossref
Peter Valent. (2008) Emerging stem cell concepts for imatinib-resistant chronic myeloid leukaemia: implications for the biology, management, and therapy of the disease. British Journal of Haematology 142:3, pages 361-378.
Crossref
Crossref